BCRX Historical Earnings image   This BCRX historical earnings page last updated 5/9/2022
BCRX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/5/20220.05B
Q4 20212/23/20220.05B
Q3 202111/3/20210.04B
Q2 20218/5/20210.05B
Q1 20215/6/20210.02B
Q4 20202/25/20210.00B
Q3 202011/5/20200.01B
Q2 20208/6/20200.00B
Q1 20205/6/20200.00B
Q4 20193/5/20200.04B
Q3 201911/6/20190.00B
Q2 20198/6/20190.00B
Q1 20195/8/20190.01B
Q4 20183/4/20192.73M
Q3 201811/6/20181.45M
Q2 20188/7/201812.49M
Q1 20185/8/20183.98M
Q4 20172/27/20183.89M
Q3 201711/7/20178.76M
Q2 20178/7/20173.10M
Q1 20175/4/20179.44M
Q4 20162/27/20178.98M
Q3 201611/7/20167.76M
Q2 20168/4/20164.79M
Q1 20165/5/20164.82M
Q4 20152/23/20164.60M
Q3 201511/5/201510.99M
Q2 20158/7/201525.84M
Q1 20155/8/20156.83M
Q4 20142/18/20155.45M
Q3 201411/6/20143.20M
Q2 20148/5/20141.47M
Q1 20145/8/20143.46M
Q4 20132/26/201410.60M
Q3 201311/5/20132.39M
Q2 20138/8/2013820000
Q1 20135/7/20133.55M
Q4 20122/19/20134.10M
Q3 201211/7/20125.76M
Q2 20128/2/20124.21M
BCRX Historical Earnings EPS
Data adjusted for BCRX split history

PeriodHistorical Earnings DateGAAP
Q1 20225/5/2022-0.400
Q4 20212/23/2022-0.400
Q3 202111/3/2021-0.330
Q2 20218/5/2021-0.240
Q1 20215/6/2021-0.360
Q4 20202/25/2021-0.340
Q3 202011/5/2020-0.260
Q2 20208/6/2020-0.240
Q1 20205/6/2020-0.240
Q4 20193/5/2020-0.020
Q3 201911/6/2019-0.340
Q2 20198/6/2019-0.340
Q1 20195/8/2019-0.280
Q4 20183/4/2019-0.25
Q3 201811/6/2018-0.28
Q2 20188/7/2018-0.19
Q1 20185/8/2018-0.26
Q4 20172/27/2018-0.2
Q3 201711/7/2017-0.18
Q2 20178/7/2017-0.21
Q1 20175/4/2017-0.19
Q4 20162/27/2017-0.06
Q3 201611/7/2016-0.16
Q2 20168/4/2016-0.22
Q1 20165/5/2016-0.31
Q4 20152/23/2016-0.25
Q3 201511/5/2015-0.2
Q2 20158/7/20150.06
Q1 20155/8/2015-0.21
Q4 20142/18/2015-0.16
Q3 201411/6/2014-0.12
Q2 20148/5/2014-0.23
Q1 20145/8/2014-0.17
Q4 20132/26/2014-0.09
Q3 201311/5/2013-0.14
Q2 20138/8/2013-0.23
Q1 20135/7/2013-0.09
Q4 20122/19/2013-0.22
Q3 201211/7/2012-0.19
Q2 20128/2/2012-0.25
Quotes delayed 20 minutes

Email EnvelopeFree BCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biocryst Pharmaceuticals (BCRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BDSI Past Earnings
BDSX Past Earnings
BDTX Past Earnings
BDX Past Earnings
BEAM Past Earnings
BFLY Past Earnings
BHG Past Earnings
BIIB Past Earnings
BIO Past Earnings
BIOC Past Earnings
What was the record high BCRX historical earnings result?
In terms of earnings or revenue, what is the best BCRX historical earnings result that Biocryst Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest BCRX historical earnings result was set in Q2 2015, when Biocryst Pharmaceuticals posted results of 0.06/share. The most successful revenue quarter within our data set was Q2 2021 when Biocryst Pharmaceuticals reported revenue of 0.05B.

What was the lowest Biocryst Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest BCRX has reported, and when?

✔️Accepted answer: Within our data set, the lowest BCRX historical earnings result was set in Q1 2022, when Biocryst Pharmaceuticals posted results of -0.400/share. The smallest revenue quarter within our data set was Q2 2013 when Biocryst Pharmaceuticals reported revenue of 820000.

On this page we presented the BCRX historical earnings date information for Biocryst Pharmaceuticals. Reviewing that BCRX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2015, when BCRX posted gaap of 0.06/share. Meanwhile the lowest BCRX historical earnings result was in Q1 2022, when BCRX posted gaap of -0.400/share. Moving to Biocryst Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2021 when BCRX reported 0.05B in revenue, while the smallest revenue quarter was Q2 2013 when BCRX reported 820000 in revenue.

For self directed investors doing their due diligence on BCRX or any other given stock, their research can benefit from looking into all of the Biocryst Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Biocryst Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for BCRX. Thanks for visiting, and the next time you need to research BCRX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: ASNA shares outstanding history, ETFs Holding MOS, YGMZ shares outstanding history.

 

BCRX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.